Samsung Biologics Selects QUMAS Platform to Manage Compliance Across the Organization
CORK, IRELAND — (Marketwire) — 12/20/11 — announced today that it has been selected by to provide an integrated regulatory compliance platform. Samsung Biologics, which forms part of the Samsung Group, was established in February 2011 and aims to be a leader in the biopharmaceutical manufacturing industry, offering world-class mammalian cell-based cGMP contract manufacturing services.Samsung Biologics has started construction of a new manufacturing facility near Seoul and it is anticipat